A human milk oligosaccharide (HMO) called 2’FL has shown potential in improving the cognitive development of babies. The research, by investigators at Children’s Hospital Los Angeles and the University of California, San Diego, US was published yesterday in PLOS ONE. It marks the first study of its kind done in humans and comes as the […]
FrieslandCampina DOMO’s new human milk oligosaccharide (HMO) ingredient, 2’-fucosyllactose (2’-FL), has been officially certified for use in infant formula in both European and US markets. The ingredient has received EU novel food approval and achieved GRAS (Generally Recognized as Safe) status from the Food and Drug Administration (FDA) in the US. The company reports that […]
